Chitosan Nanoparticles as an Innovative Approach Against Liver Fibrosis
Liver fibrosis is a serious disease characterized by excessive deposition of connective tissue, which can progress to cirrhosis if left untreated. Conventional therapeutic approaches are often insufficient to halt the remodeling of liver tissue. In pharmaceutical research, nanotechnology-based drug delivery systems are therefore gaining increasing importance – particularly those based on chitosan nanoparticles.
Microfluidics for the production of chitosan-TPP nanoparticles
Microfluidics can precisely control the physiochemical properties of nanoparticles by mixing to the nanoliter. For this reason, nanoparticles for the transport of peptide drugs are to be developed in the study presented here with the help of chitosan from Heppe Medical Chitosan GmbH.